nach oben

Acta Neuropathologica

Erschienen in:

01.04.2014 | Review

Olfactory bulb involvement in neurodegenerative diseases

verfasst von: Johannes Attems, Lauren Walker, Kurt A. Jellinger

Erschienen in: Acta Neuropathologica | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Olfactory dysfunction is a common and early symptom of many neurodegenerative diseases, particularly of Parkinson’s disease and other synucleinopathies, Alzheimer’s disease (AD), and mild cognitive impairment heralding its progression to dementia. The neuropathologic changes of olfactory dysfunction in neurodegenerative diseases may involve the olfactory epithelium, olfactory bulb/tract, primary olfactory cortices, and their secondary targets. Olfactory dysfunction is related to deposition of pathological proteins, α-synuclein, hyperphosphorylated tau protein, and neurofilament protein in these areas, featured by neurofibrillary tangles, Lewy bodies and neurites inducing a complex cascade of molecular processes including oxidative damage, neuroinflammation, and cytosolic disruption of cellular processes leading to cell death. Damage to cholinergic, serotonergic, and noradrenergic systems is likely involved, since such damage is most marked in those diseases with severe anosmia. Recent studies of olfactory dysfunction have focused its potential as an early biomarker for the diagnosis of neurodegenerative disorders and their disease progression. Here, we summarize the current knowledge on neuropathological and pathophysiological changes of the olfactory system in the most frequent neurodegenerative diseases, in particular AD and synucleinopathies. We also present neuropathological findings in the olfactory bulb and tract in a large autopsy cohort (n = 536, 57.8 % female, mean age 81.3 years). The severity of olfactory bulb HPτ, Aβ, and αSyn pathology correlated and increased significantly (P < 0.001) with increasing neuritic Braak stages, Thal Aβ phases, and cerebral Lewy body pathology, respectively. Hence, further studies are warranted to investigate the potential role of olfactory biopsies (possibly restricted to the olfactory epithelium) in the diagnostic process of neurodegenerative diseases in particular in clinical drug trials to identify subjects showing early, preclinical stages of neurodegeneration and to stratify clinically impaired cohorts according to the underlying cerebral neuropathology.

Ahlskog JE, Waring SC, Petersen RC, Esteban-Santillan C, Craig UK, O’Brien PC, Plevak MF, Kurland LT (1998) Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia. Neurology 51:1672–1677PubMed

Alcalay RN, Siderowf A, Ottman R, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Louis E, Ruiz D, Waters C, Fahn S, Cote L, Frucht S, Ford B, Orbe-Reilly M, Ross B, Verbitsky M, Kisselev S, Comella C, Colcher A, Jennings D, Nance M, Bressman S, Scott WK, Tanner C, Mickel S, Rezak M, Novak KE, Friedman JH, Pfeiffer R, Marsh L, Hiner B, Clark LN, Marder K (2011) Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology 76:319–326PubMedCentralPubMed

Alves G, Forsaa EB, Pedersen KF, Dreetz Gjerstad M, Larsen JP (2008) Epidemiology of Parkinson’s disease. J Neurol 255(Suppl 5):18–32PubMed

Ansoleaga B, Garcia-Esparcia P, Llorens F, Moreno J, Aso E, Ferrer I (2013) Dysregulation of brain olfactory and taste receptors in AD, PSP and CJD, and AD-related model. Neuroscience 248C:369–382PubMed

Arnold SE, Han LY, Moberg PJ, Turetsky BI, Gur RE, Trojanowski JQ, Hahn CG (2001) Dysregulation of olfactory receptor neuron lineage in schizophrenia. Arch Gen Psychiatry 58:829–835PubMed

Arnold SE, Lee EB, Moberg PJ, Stutzbach L, Kazi H, Han LY, Lee VM, Trojanowski JQ (2010) Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease. Ann Neurol 67:462–469PubMedCentralPubMed

Attems J, Lintner F, Jellinger KA (2005) Olfactory involvement in aging and Alzheimer’s disease: an autopsy study. J Alzheimers Dis 7:149–157 (discussion 173–180)PubMed

Attems J, Jellinger KA (2006) Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Clin Neuropathol 25:265–271PubMed

Attems J, Alpar A, Spence L, McParland S, Heikenwalder M, Uhlen M, Tanila H, Hokfelt TG, Harkany T (2012) Clusters of secretagogin-expressing neurons in the aged human olfactory tract lack terminal differentiation. Proc Natl Acad Sci USA 109:6259–6264PubMedCentralPubMed

10.

Attems J, Jellinger K (2013) Neuropathological correlates of cerebral multimorbidity. Curr Alzheimer Res 10:569–577PubMed

11.

Averback P (1983) Two new lesions in Alzheimer’s disease. Lancet 2:1203PubMed

12.

Baba T, Takeda A, Kikuchi A, Nishio Y, Hosokai Y, Hirayama K, Hasegawa T, Sugeno N, Suzuki K, Mori E, Takahashi S, Fukuda H, Itoyama Y (2011) Association of olfactory dysfunction and brain. Metabolism in Parkinson’s disease. Mov Disord 26:621–628PubMed

13.

Baba T, Kikuchi A, Hirayama K, Nishio Y, Hosokai Y, Kanno S, Hasegawa T, Sugeno N, Konno M, Suzuki K, Takahashi S, Fukuda H, Aoki M, Itoyama Y, Mori E, Takeda A (2012) Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson’s disease: a 3 year longitudinal study. Brain 135:161–169PubMed

14.

Babizhayev MA, Deyev AI, Yegorov YE (2011) Olfactory dysfunction and cognitive impairment in age-related neurodegeneration: prevalence related to patient selection, diagnostic criteria and therapeutic treatment of aged clients receiving clinical neurology and community-based care. Curr Clin Pharmacol 6:236–259PubMed

15.

Bahar-Fuchs A, Chetelat G, Villemagne VL, Moss S, Pike K, Masters CL, Rowe C, Savage G (2010) Olfactory deficits and amyloid-beta burden in Alzheimer’s disease, mild cognitive impairment, and healthy aging: a PiB PET study. J Alzheimers Dis 22:1081–1087PubMed

16.

Bahar-Fuchs A, Moss S, Rowe C, Savage G (2010) Olfactory performance in AD, aMCI, and healthy ageing: a unirhinal approach. Chem Senses 35:855–862PubMed

17.

Barresi M, Ciurleo R, Giacoppo S, Foti Cuzzola V, Celi D, Bramanti P, Marino S (2012) Evaluation of olfactory dysfunction in neurodegenerative diseases. J Neurol Sci 323:16–24PubMed

18.

Barrios FA, Gonzalez L, Favila R, Alonso ME, Salgado PM, Diaz R, Fernandez-Ruiz J (2007) Olfaction and neurodegeneration in HD. NeuroReport 18:73–76PubMed

19.

Beach TG, White CL 3rd, Hladik CL, Sabbagh MN, Connor DJ, Shill HA, Sue LI, Sasse J, Bachalakuri J, Henry-Watson J, Akiyama H, Adler CH (2009) Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 117:169–174PubMedCentralPubMed

20.

Belluscio L, Gold GH, Nemes A, Axel R (1998) Mice deficient in G(olf) are anosmic. Neuron 20:69–81PubMed

21.

Benarroch EE (2010) Olfactory system: functional organization and involvement in neurodegenerative disease. Neurology 75:1104–1109PubMed

22.

Berendse HW, Roos DS, Raijmakers P, Doty RL (2011) Motor and non-motor correlates of olfactory dysfunction in Parkinson’s disease. J Neurol Sci 310:21–24PubMed

23.

Bhatnagar KP, Kennedy RC, Baron G, Greenberg RA (1987) Number of mitral cells and the bulb volume in the aging human olfactory bulb: a quantitative morphological study. Anat Rec 218:73–87PubMed

24.

Boesveldt S, Verbaan D, Knol DL, Visser M, van Rooden SM, van Hilten JJ, Berendse HW (2008) A comparative study of odor identification and odor discrimination deficits in Parkinson’s disease. Mov Disord 23:1984–1990PubMed

25.

Bohnen NI, Gedela S, Kuwabara H, Constantine GM, Mathis CA, Studenski SA, Moore RY (2007) Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease. J Neurol 254:84–90PubMed

26.

Bohnen NI, Gedela S, Herath P, Constantine GM, Moore RY (2008) Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity. Neurosci Lett 447:12–16PubMedCentralPubMed

27.

Bohnen NI, Muller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA (2010) Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease. Brain 133:1747–1754PubMedCentralPubMed

28.

Bohnen NI, Muller ML (2013) In vivo neurochemical imaging of olfactory dysfunction in Parkinson’s disease. J Neural Transm 120:571–576PubMed

29.

Bovi T, Antonini A, Ottaviani S, Antonioli A, Cecchini MP, Di Francesco V, Bassetto MA, Zamboni M, Fiaschi A, Moretto G, Sbarbati A, Osculati F, Tinazzi M (2010) The status of olfactory function and the striatal dopaminergic system in drug-induced parkinsonism. J Neurol 257:1882–1889PubMed

30.

Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211PubMed

31.

Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318:121–134PubMed

32.

Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404PubMedCentralPubMed

33.

Braga-Neto P, Felicio AC, Hoexter MQ, Pedroso JL, Dutra LA, Alessi H, Minett T, Santos-Galduroz RF, da Rocha AJ, Garcia LA, Bertolucci PH, Bressan RA, Barsottini OG (2012) Cognitive and olfactory deficits in Machado-Joseph disease: a dopamine transporter study. Parkinsonism Relat Disord 18:854–858PubMed

34.

Brodoehl S, Klingner C, Volk GF, Bitter T, Witte OW, Redecker C (2012) Decreased olfactory bulb volume in idiopathic Parkinson’s disease detected by 3.0-tesla magnetic resonance imaging. Mov Disord 27:1019–1025PubMed

35.

Brunet LJ, Gold GH, Ngai J (1996) General anosmia caused by a targeted disruption of the mouse olfactory cyclic nucleotide-gated cation channel. Neuron 17:681–693PubMed

36.

Busenbark KL, Huber SJ, Greer G, Pahwa R, Koller WC (1992) Olfactory function in essential tremor. Neurology 42:1631–1632PubMed

37.

Cai Y, Xue ZQ, Zhang XM, Li MB, Wang H, Luo XG, Cai H, Yan XX (2012) An age-related axon terminal pathology around the first olfactory relay that involves amyloidogenic protein overexpression without plaque formation. Neuroscience 215:160–173PubMed

38.

Cao L, Schrank BR, Rodriguez S, Benz EG, Moulia TW, Rickenbacher GT, Gomez AC, Levites Y, Edwards SR, Golde TE, Hyman BT, Barnea G, Albers MW (2012) Abeta alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo. Nat Commun 3:1009PubMedCentralPubMed

39.

Cassano T, Romano A, Macheda T, Colangeli R, Cimmino CS, Petrella A, LaFerla FM, Cuomo V, Gaetani S (2011) Olfactory memory is impaired in a triple transgenic model of Alzheimer disease. Behav Brain Res 224:408–412PubMed

40.

Cheng N, Cai H, Belluscio L (2011) In vivo olfactory model of APP-induced neurodegeneration reveals a reversible cell-autonomous function. J Neurosci 31:13699–13704PubMedCentralPubMed

41.

Cheng N, Bai L, Steuer E, Belluscio L (2013) Olfactory functions scale with circuit restoration in a rapidly reversible Alzheimer’s disease model. J Neurosci 33:12208–12217PubMedCentralPubMed

42.

Chiba Y, Fujishiro H, Iseki E, Ota K, Kasanuki K, Hirayasu Y, Satoa K (2012) Retrospective survey of prodromal symptoms in dementia with Lewy bodies: comparison with Alzheimer’s disease. Dement Geriatr Cogn Disord 33:273–281PubMed

43.

Chiu WH, Carlsson T, Depboylu C, Hoglinger GU, Oertel WH, Ries V (2013) Selegiline normalizes, while l-DOPA sustains the increased number of dopamine neurons in the olfactory bulb in a 6-OHDA mouse model of Parkinson’s disease. Neuropharmacology 79C:212–221

44.

Christen-Zaech S, Kraftsik R, Pillevuit O, Kiraly M, Martins R, Khalili K, Miklossy J (2003) Early olfactory involvement in Alzheimer’s disease. Can J Neurol Sci 30:20–25PubMed

45.

Conti MZ, Vicini-Chilovi B, Riva M, Zanetti M, Liberini P, Padovani A, Rozzini L (2013) Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer’s disease. Arch Clin Neuropsychol 28:391–399PubMed

46.

Corona C, Porcario C, Martucci F, Iulini B, Manea B, Gallo M, Palmitessa C, Maurella C, Mazza M, Pezzolato M, Acutis P, Casalone C (2009) Olfactory system involvement in natural scrapie disease. J Virol 83:3657–3667PubMedCentralPubMed

47.

Crino PB, Martin JA, Hill WD, Greenberg B, Lee VM, Trojanowski JQ (1995) Beta-Amyloid peptide and amyloid precursor proteins in olfactory mucosa of patients with Alzheimer’s disease, Parkinson’s disease, and Down syndrome. Ann Otol Rhinol Laryngol 104:655–661PubMed

48.

Cross DJ, Anzai Y, Petrie EC, Martin N, Richards TL, Maravilla KR, Peskind ER, Minoshima S (2013) Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment. J Nucl Med 54:1278–1284PubMed

49.

Davies DC, Brooks JW, Lewis DA (1993) Axonal loss from the olfactory tracts in Alzheimer’s disease. Neurobiol Aging 14:353–357PubMed

50.

Demarquay G, Ryvlin P, Royet JP (2007) Olfaction and neurological diseases: a review of the literature. Rev Neurol (Paris) 163:155–167

51.

Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, Bell K, Stern Y, Mayeux R (2000) Olfactory deficits in patients with mild cognitive impairment predict Alzheimer’s disease at follow-up. Am J Psychiatry 157:1399–1405PubMed

52.

Devanand DP, Tabert MH, Cuasay K, Manly JJ, Schupf N, Brickman AM, Andrews H, Brown TR, DeCarli C, Mayeux R (2010) Olfactory identification deficits and MCI in a multi-ethnic elderly community sample. Neurobiol Aging 31:1593–1600PubMedCentralPubMed

53.

Dibattista M, Massimino ML, Maurya DK, Menini A, Bertoli A, Sorgato MC (2011) The cellular prion protein is expressed in olfactory sensory neurons of adult mice but does not affect the early events of the olfactory transduction pathway. Chem Senses 36:791–797PubMed

54.

Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H (2008) Olfaction in patients with mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging 29:693–706PubMed

55.

Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237–1244PubMed

56.

Doty RL, Perl DP, Steele JC, Chen KM, Pierce JD Jr, Reyes P, Kurland LT (1991) Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer’s and idiopathic Parkinson’s disease. Neurology 41(Suppl. 2):77–80PubMed

57.

Doty RL, Singh A, Tetrud J, Langston JW (1992) Lack of major olfactory dysfunction in MPTP-induced parkinsonism. Ann Neurol 32:97–100PubMed

58.

Doty RL (2007) Olfaction in Parkinson’s disease. Parkinsonism Relat Disord 13(Suppl 3):S225–S228PubMed

59.

Doty RL (2008) The olfactory vector hypothesis of neurodegenerative disease: is it viable? Ann Neurol 63:7–15PubMed

60.

Doty RL (2012) Olfaction in Parkinson’s disease and related disorders. Neurobiol Dis 46:527–552PubMedCentralPubMed

61.

Doty RL (2012) Olfactory dysfunction in Parkinson disease. Nat Rev Neurol 8:329–339PubMed

62.

Duda JE, Shah U, Arnold SE, Lee VM, Trojanowski JQ (1999) The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Exp Neurol 160:515–522PubMed

63.

Duda JE (2010) Olfactory system pathology as a model of Lewy neurodegenerative disease. J Neurol Sci 289:49–54PubMed

64.

Dudova I, Hrdlicka M (2013) Olfactory functions are not associated with autism severity in autism spectrum disorders. Neuropsychiatr Dis Treat 9:1847–1851PubMedCentralPubMed

65.

Dziewulska D, Doi H, Fasano A, Erro R, Fatehi F, Fekete R, Gatto EM, Pablos EG, Lehn A, Miyajima H, Piperno A, Pellechia MT, Wu YR, Yoshida K, Zarruk JG, Jingli S, Schrag A, McNeill A (2013) Olfactory impairment and pathology in neurodegenerative disorders with brain iron accumulation. Acta Neuropathol 126:151–153PubMed

66.

Evidente VG, Esteban RP, Hernandez JL, Natividad FF, Advincula J, Gwinn-Hardy K, Hardy J, Singleton A (2004) Smell testing is abnormal in ‘lubag’ or X-linked dystonia-parkinsonism: a pilot study. Parkinsonism Relat Disord 10:407–410PubMed

67.

Fantini ML, Postuma RB, Montplaisir J, Ferini-Strambi L (2006) Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder. Brain Res Bull 70:386–390PubMed

68.

Fernandez-Ruiz J, Diaz R, Hall-Haro C, Vergara P, Fiorentini A, Nunez L, Drucker-Colin R, Ochoa A, Yescas P, Rasmussen A, Alonso ME (2003) Olfactory dysfunction in hereditary ataxia and basal ganglia disorders. NeuroReport 14:1339–1341PubMed

69.

Ferraris A, Ialongo T, Passali GC, Pellecchia MT, Brusa L, Laruffa M, Guidubaldi A, Paludetti G, Albanese A, Barone P, Dallapiccola B, Valente EM, Bentivoglio AR (2009) Olfactory dysfunction in Parkinsonism caused by PINK1 mutations. Mov Disord 24:2350–2357PubMed

70.

Fleming SM, Tetreault NA, Mulligan CK, Hutson CB, Masliah E, Chesselet MF (2008) Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. Eur J Neurosci 28:247–256PubMedCentralPubMed

71.

Forster S, Vaitl A, Teipel SJ, Yakushev I, Mustafa M, la Fougere C, Rominger A, Cumming P, Bartenstein P, Hampel H, Hummel T, Buerger K, Hundt W, Steinbach S (2010) Functional representation of olfactory impairment in early Alzheimer’s disease. J Alzheimers Dis 22:581–591PubMed

72.

Fujishiro H, Tsuboi Y, Lin WL, Uchikado H, Dickson DW (2008) Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer’s disease with amygdala Lewy bodies. Acta Neuropathol 116:17–24PubMedCentralPubMed

73.

Funabe S, Takao M, Saito Y, Hatsuta H, Sugiyama M, Ito S, Kanemaru K, Sawabe M, Arai T, Mochizuki H, Hattori N, Murayama S (2013) Neuropathologic analysis of Lewy-related alpha-synucleinopathy in olfactory mucosa. Neuropathology 33:47–58PubMed

74.

Furtado S, Wszolek ZK (2013) Olfactory dysfunction. In: Pfeiffer RF, Bodis-Wollner I (eds) Parkinson’s disease and nonmotor dysfunction. Humana Press Inc., Totowa, pp 245–253

75.

Fusetti M, Fioretti AB, Silvagni F, Simaskou M, Sucapane P, Necozione S, Eibenstein A (2010) Smell and preclinical Alzheimer disease: study of 29 patients with amnesic mild cognitive impairment. J Otolaryngol Head Neck Surg 39:175–181PubMed

76.

Gallarda BW, Lledo PM (2012) Adult neurogenesis in the olfactory system and neurodegenerative disease. Curr Mol Med 12:1253–1260PubMed

77.

Garcia-Esparcia P, Schluter A, Carmona M, Moreno J, Ansoleaga B, Torrejon-Escribano B, Gustincich S, Pujol A, Ferrer I (2013) Functional genomics reveals dysregulation of cortical olfactory receptors in Parkinson disease: novel putative chemoreceptors in the human brain. J Neuropathol Exp Neurol 72:524–539PubMed

78.

Garland EM, Raj SR, Peltier AC, Robertson D, Biaggioni I (2011) A cross-sectional study contrasting olfactory function in autonomic disorders. Neurology 76:456–460PubMedCentralPubMed

79.

Getchell ML, Shah DS, Buch SK, Davis DG, Getchell TV (2003) 3-Nitrotyrosine immunoreactivity in olfactory receptor neurons of patients with Alzheimer’s disease: implications for impaired odor sensitivity. Neurobiol Aging 24:663–673PubMed

80.

Glass PG, Lees AJ, Mathias C, Mason L, Best C, Williams DR, Katzenschlager R, Silveira-Moriyama L (2012) Olfaction in pathologically proven patients with multiple system atrophy. Mov Disord 27:327–328PubMed

81.

Goker-Alpan O, Lopez G, Vithayathil J, Davis J, Hallett M, Sidransky E (2008) The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol 65:1353–1357PubMedCentralPubMed

82.

Goldstein DS, Sewell L (2009) Olfactory dysfunction in pure autonomic failure: implications for the pathogenesis of Lewy body diseases. Parkinsonism Relat Disord 15:516–520PubMed

83.

Goldstein DS, Sewell L, Holmes C (2010) Association of anosmia with autonomic failure in Parkinson disease. Neurology 74:245–251PubMedCentralPubMed

84.

Graves AB, Bowen JD, Rajaram L, McCormick WC, McCurry SM, Schellenberg GD, Larson EB (1999) Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology 53:1480–1487PubMed

85.

Haehner A, Hummel T, Reichmann H (2013) A clinical approach towards smell loss in Parkinson’s disease. J Parkinsons Dis. doi:10.3233/JPD-130278

86.

Haehner A, Hummel T, Wolz M, Klingelhofer L, Fauser M, Storch A, Reichmann H (2013) Effects of rasagiline on olfactory function in patients with Parkinson’s disease. Mov Disord 28:2023–2027

87.

Hawkes C (2003) Olfaction in neurodegenerative disorder. Mov Disord 18:364–372PubMed

88.

Hawkes CH, Shephard BC, Daniel SE (1997) Olfactory dysfunction in Parkinson’s disease. J Neurol Neurosurg Psychiatry 62:436–446PubMedCentralPubMed

89.

Hawkes CH, Doty RL (2009) The neurology of olfaction. Cambridge University Press, Cambridge

90.

Hensiek AE, Bhatia KP, Hawkes CH (2000) Olfactory function in drug-induced parkinsonism. J Neurol 247:P303

91.

Herting B, Bietenbeck S, Scholz K, Hahner A, Hummel T, Reichmann H (2008) Olfactory dysfunction in Parkinson’s disease: its role as a new cardinal sign in early and differential diagnosis. Nervenarzt 79:175–184PubMed

92.

Herting B, Schulze S, Reichmann H, Haehner A, Hummel T (2008) A longitudinal study of olfactory function in patients with idiopathic Parkinson’s disease. J Neurol 255:367–370PubMed

93.

Hirai T, Kojima S, Shimada A, Umemura T, Sakai M, Itakura C (1996) Age-related changes in the olfactory system of dogs. Neuropathol Appl Neurobiol 22:531–539PubMed

94.

Hock C, Golombowski S, Muller-Spahn F, Peschel O, Riederer A, Probst A, Mandelkow E, Unger J (1998) Histological markers in nasal mucosa of patients with Alzheimer’s disease. Eur Neurol 40:31–36PubMed

95.

Hovakimyan M, Meyer A, Lukas J, Luo J, Gudziol V, Hummel T, Rolfs A, Wree A, Witt M (2013) Olfactory deficits in Niemann-Pick Type C1 (NPC1) disease. PLoS ONE 8:e82216PubMedCentralPubMed

96.

Hower RE, Rick JH, Balderston CC, Weintraub D, Siderowf AD, Stern M, Moberg PJ, Duda JE (2008) Olfactory dysfunction and Parkinson’s disease progression. Neurology 70:A397–A398

97.

Hoyles K, Sharma JC (2013) Olfactory loss as a supporting feature in the diagnosis of Parkinson’s disease: a pragmatic approach. J Neurol 260:2951–2958PubMed

98.

Hu J, Wang X, Liu D, Wang Q, Zhu LQ (2012) Olfactory deficits induce neurofilament hyperphosphorylation. Neurosci Lett 506:180–183PubMed

99.

Hubbard PS, Esiri MM, Reading M, McShane R, Nagy Z (2007) Alpha-synuclein pathology in the olfactory pathways of dementia patients. J Anat 211:117–124PubMedCentralPubMed

100.

Huisman E, Uylings HB, Hoogland PV (2004) A 100 % increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson’s disease. Mov Disord 19:687–692PubMed

101.

Huisman E, Uylings HB, Hoogland PV (2008) Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson’s disease patients. Mov Disord 23:1407–1413PubMed

102.

Hussain A, Luong M, Pooley A, Nathan BP (2013) Isoform-specific effects of apoE on neurite outgrowth in olfactory epithelium culture. J Biomed Sci 20:49PubMedCentralPubMed

103.

Ibarretxe-Bilbao N, Junque C, Marti MJ, Valldeoriola F, Vendrell P, Bargallo N, Zarei M, Tolosa E (2010) Olfactory impairment in Parkinson’s disease and white matter abnormalities in central olfactory areas: a voxel-based diffusion tensor imaging study. Mov Disord 25:1888–1894PubMed

104.

Iijima M, Osawa M, Momose M, Kobayakawa T, Saito S, Iwata M, Uchiyama S (2010) Cardiac sympathetic degeneration correlates with olfactory function in Parkinson’s disease. Mov Disord 25:1143–1149PubMed

105.

Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M, Sanchez-Valle R, Vilaseca I, Lomena F, Vilas D, Llado A, Gaig C, Santamaria J (2013) Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 12:443–453PubMed

106.

Jafek BW, Murrow B, Michaels R, Restrepo D, Linschoten M (2002) Biopsies of human olfactory epithelium. Chem Senses 27:623–628PubMed

107.

Jellinger KA (2009) Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 117:215–216; author reply 217–218

108.

Kaakkola S, Palo J, Malmberg H, Sulkava R, Virtanen I (1994) Neurofilament profile in olfactory mucosa of patients with a clinical diagnosis of Alzheimer’s disease. Virchows Arch 424:315–319PubMed

109.

Kang P, Kloke J, Jain S (2012) Olfactory dysfunction and parasympathetic dysautonomia in Parkinson’s disease. Clin Auton Res 22:161–166PubMedCentralPubMed

110.

Katzenschlager R, Lees AJ (2004) Olfaction and Parkinson’s syndromes: its role in differential diagnosis. Curr Opin Neurol 17:417–423PubMed

111.

Katzenschlager R, Zijlmans J, Evans A, Watt H, Lees AJ (2004) Olfactory function distinguishes vascular parkinsonism from Parkinson’s disease. J Neurol Neurosurg Psychiatry 75:1749–1752PubMedCentralPubMed

112.

Kertelge L, Bruggemann N, Schmidt A, Tadic V, Wisse C, Dankert S, Drude L, van der Vegt J, Siebner H, Pawlack H, Pramstaller PP, Behrens MI, Ramirez A, Reichel D, Buhmann C, Hagenah J, Klein C, Lohmann K, Kasten M (2010) Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson’s disease. Mov Disord 25:2665–2669PubMed

113.

Khan NL, Katzenschlager R, Watt H, Bhatia KP, Wood NW, Quinn N, Lees AJ (2004) Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease. Neurology 62:1224–1226PubMed

114.

Kim YH, Lussier S, Rane A, Choi SW, Andersen JK (2011) Inducible dopaminergic glutathione depletion in an alpha-synuclein transgenic mouse model results in age-related olfactory dysfunction. Neuroscience 172:379–386PubMedCentralPubMed

115.

Kishikawa M, Iseki M, Nishimura M, Sekine I, Fujii H (1990) A histopathological study on senile changes in the human olfactory bulb. Acta Pathol Jpn 40:255–260PubMed

116.

Kovacs I, Torok I, Zombori J, Kasa P (1998) Cholinergic structures and neuropathologic alterations in the olfactory bulb of Alzheimer’s disease brain samples. Brain Res 789:167–170PubMed

117.

Kovacs T, Cairns NJ, Lantos PL (1999) beta-Amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer’s disease. Neuropathol Appl Neurobiol 25:481–491PubMed

118.

Kovacs T, Cairns NJ, Lantos PL (2001) Olfactory centres in Alzheimer’s disease: olfactory bulb is involved in early Braak’s stages. NeuroReport 12:285–288PubMed

119.

Kovacs T (2013) The olfactory system in Alzheimer’s disease: pathology, pathophysiology and pathway for therapy. Translat Neurosci 4:34–45

120.

Kranick SM, Duda JE (2008) Olfactory dysfunction in Parkinson’s disease. Neurosignals 16:35–40PubMed

121.

Krismer F, Wenning GK, Li Y, Poewe W, Stefanova N (2013) Intact olfaction in a mouse model of multiple system atrophy. PLoS ONE 8:e64625PubMedCentralPubMed

122.

Kruger S, Haehner A, Thiem C, Hummel T (2008) Neuroleptic-induced parkinsonism is associated with olfactory dysfunction. J Neurol 255:1574–1579PubMed

123.

Kulkarni-Narla A, Getchell TV, Schmitt FA, Getchell ML (1996) Manganese and copper-zinc superoxide dismutases in the human olfactory mucosa: increased immunoreactivity in Alzheimer’s disease. Exp Neurol 140:115–125PubMed

124.

Lang CJ, Schwandner K, Hecht M (2011) Do patients with motor neuron disease suffer from disorders of taste or smell? Amyotroph Lateral Scler 12:368–371PubMed

125.

Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46:598–605PubMed

126.

Larsson M, Farde L, Hummel T, Witt M, Lindroth NE, Backman L (2009) Age-related loss of olfactory sensitivity: association to dopamine transporter binding in putamen. Neuroscience 161:422–426PubMed

127.

Lazic SE, Goodman AO, Grote HE, Blakemore C, Morton AJ, Hannan AJ, van Dellen A, Barker RA (2007) Olfactory abnormalities in Huntington’s disease: decreased plasticity in the primary olfactory cortex of R6/1 transgenic mice and reduced olfactory discrimination in patients. Brain Res 1151:219–226PubMed

128.

Le Pichon CE, Firestein S (2008) Expression and localization of the prion protein PrP(C) in the olfactory system of the mouse. J Comp Neurol 508:487–499PubMed

129.

Lee JH, Goedert M, Hill WD, Lee VM, Trojanowski JQ (1993) Tau proteins are abnormally expressed in olfactory epithelium of Alzheimer patients and developmentally regulated in human fetal spinal cord. Exp Neurol 121:93–105PubMed

130.

Lee YH, Simmons MM, Hawkins SA, Spencer YI, Webb P, Stack MJ, Wells GA (2009) Detection of pathologic prion protein in the olfactory bulb of natural and experimental bovine spongiform encephalopathy affected cattle in Great Britain. Vet Pathol 46:59–62PubMed

131.

Lehrner J, Pusswald G, Gleiss A, Auff E, Dal-Bianco P (2009) Odor identification and self-reported olfactory functioning in patients with subtypes of mild cognitive impairment. Clin Neuropsychol 23:818–830PubMed

132.

Leon-Sarmiento FE, Bayona EA, Bayona-Prieto J, Osman A, Doty RL (2012) Profound olfactory dysfunction in myasthenia gravis. PLoS ONE 7:e45544PubMedCentralPubMed

133.

Lerner A, Bagic A (2008) Olfactory pathogenesis of idiopathic Parkinson disease revisited. Mov Disord 23:1076–1084PubMed

134.

Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487–1491PubMed

135.

Li W, Howard JD, Gottfried JA (2010) Disruption of odour quality coding in piriform cortex mediates olfactory deficits in Alzheimer’s disease. Brain 133:2714–2726PubMedCentralPubMed

136.

Lischka FW, Gomez G, Yee KK, Dankulich-Nagrudny L, Lo L, Haskins ME, Rawson NE (2008) Altered olfactory epithelial structure and function in feline models of mucopolysaccharidoses I and VI. J Comp Neurol 511:360–372PubMedCentralPubMed

137.

Liu Q, Li A, Gong L, Zhang L, Wu N, Xu F (2013) Decreased coherence between the two olfactory bulbs in Alzheimer’s disease model mice. Neurosci Lett 545:81–85PubMed

138.

Loopuijt LD, Sebens JB (1990) Loss of dopamine receptors in the olfactory bulb of patients with Alzheimer’s disease. Brain Res 529:239–244PubMed

139.

Luzzi S, Snowden JS, Neary D, Coccia M, Provinciali L, Lambon Ralph MA (2007) Distinct patterns of olfactory impairment in Alzheimer’s disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia 45:1823–1831PubMed

140.

Macknin JB, Higuchi M, Lee VM, Trojanowski JQ, Doty RL (2004) Olfactory dysfunction occurs in transgenic mice overexpressing human tau protein. Brain Res 1000:174–178PubMed

141.

Markopoulou K, Larsen KW, Wszolek EK, Denson MA, Lang AE, Pfeiffer RF, Wszolek ZK (1997) Olfactory dysfunction in familial parkinsonism. Neurology 49:1262–1267PubMed

142.

Marxreiter F, Nuber S, Kandasamy M, Klucken J, Aigner R, Burgmayer R, Couillard-Despres S, Riess O, Winkler J, Winner B (2009) Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein. Eur J Neurosci 29:879–890PubMed

143.

Masaoka Y, Yoshimura N, Inoue M, Kawamura M, Homma I (2007) Impairment of odor recognition in Parkinson’s disease caused by weak activations of the orbitofrontal cortex. Neurosci Lett 412:45–50PubMed

144.

May VE, Nuber S, Marxreiter F, Riess O, Winner B, Winkler J (2012) Impaired olfactory bulb neurogenesis depends on the presence of human wild-type alpha-synuclein. Neuroscience 222:343–355PubMed

145.

McCurdy RD, Feron F, Perry C, Chant DC, McLean D, Matigian N, Hayward NK, McGrath JJ, Mackay-Sim A (2006) Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses. Schizophr Res 82:163–173PubMed

146.

McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872PubMed

147.

McLaughlin NC, Westervelt HJ (2008) Odor identification deficits in frontotemporal dementia: a preliminary study. Arch Clin Neuropsychol 23:119–123PubMed

148.

Meusel T, Westermann B, Fuhr P, Hummel T, Welge-Lussen A (2010) The course of olfactory deficits in patients with Parkinson’s disease—a study based on psychophysical and electrophysiological measures. Neurosci Lett 486:166–170PubMed

149.

Mirra SS, Hart MN, Terry RD (1993) Making the diagnosis of Alzheimer’s disease. A primer for practicing pathologists. Arch Pathol Lab Med 117:132–144PubMed

150.

Miyamoto T (2012) Olfactory dysfunction in Parkinson disease and REM sleep behavior disorder. Brain Nerve 64:356–363PubMed

151.

Moessnang C, Frank G, Bogdahn U, Winkler J, Greenlee MW, Klucken J (2011) Altered activation patterns within the olfactory network in Parkinson’s disease. Cereb Cortex 21:1246–1253PubMed

152.

Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123:1–11PubMedCentralPubMed

153.

Mor E, Kano S, Colantuoni C, Sawa A, Navon R, Shomron N (2013) MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients. Neurobiol Dis 55:1–10PubMed

154.

Morley JF, Duda JE (2010) Olfaction as a biomarker in Parkinson’s disease. Biomark Med 4:661–670PubMed

155.

Morley JF, Weintraub D, Mamikonyan E, Moberg PJ, Siderowf AD, Duda JE (2011) Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson’s disease. Mov Disord 26:2051–2057PubMedCentralPubMed

156.

Moscovich M, Munhoz RP, Teive HA, Raskin S, Carvalho Mde J, Barbosa ER, Ranvaud R, Liu J, McFarland K, Ashizawa T, Lees AJ, Silveira-Moriyama L (2012) Olfactory impairment in familial ataxias. J Neurol Neurosurg Psychiatry 83:970–974PubMedCentralPubMed

157.

Mueller A, Reuner U, Landis B, Kitzler H, Reichmann H, Hummel T (2006) Extrapyramidal symptoms in Wilson’s disease are associated with olfactory dysfunction. Mov Disord 21:1311–1316PubMed

158.

Muller A, Mungersdorf M, Reichmann H, Strehle G, Hummel T (2002) Olfactory function in Parkinsonian syndromes. J Clin Neurosci 9:521–524PubMed

159.

Mundinano IC, Caballero MC, Ordonez C, Hernandez M, DiCaudo C, Marcilla I, Erro ME, Tunon MT, Luquin MR (2011) Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders. Acta Neuropathol 122:61–74PubMed

160.

Mundinano IC, Hernandez M, Dicaudo C, Ordonez C, Marcilla I, Tunon MT, Luquin MR (2013) Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys. Acta Neuropathol 126:411–425PubMed

161.

Nguyen AD, Shenton ME, Levitt JJ (2010) Olfactory dysfunction in schizophrenia: a review of neuroanatomy and psychophysiological measurements. Harv Rev Psychiatry 18:279–292PubMed

162.

Nores JM, Biacabe B, Bonfils P (2000) Olfactory disorders in Alzheimer’s disease and in Parkinson’s disease. Review of the literature. Ann Med Interne (Paris) 151:97–106

163.

Nuber S, Petrasch-Parwez E, Arias-Carrion O, Koch L, Kohl Z, Schneider J, Calaminus C, Dermietzel R, Samarina A, Boy J, Nguyen HP, Teismann P, Velavan TP, Kahle PJ, von Horsten S, Fendt M, Kruger R, Riess O (2011) Olfactory neuron-specific expression of A30P alpha-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson’s disease stages. Neurobiol Dis 44:192–204PubMed

164.

Nuber S, Tadros D, Fields J, Overk CR, Ettle B, Kosberg K, Mante M, Rockenstein E, Trejo M, Masliah E (2014) Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD. Acta Neuropathol in print. doi:10.1007/s00401-00014-01255-00405

165.

Ohm TG, Braak H (1987) Olfactory bulb changes in Alzheimer’s disease. Acta Neuropathol 73:365–369PubMed

166.

Oka H, Toyoda C, Yogo M, Mochio S (2010) Olfactory dysfunction and cardiovascular dysautonomia in Parkinson’s disease. J Neurol 257:969–976PubMed

167.

Olichney JM, Murphy C, Hofstetter CR, Foster K, Hansen LA, Thal LJ, Katzman R (2005) Anosmia is very common in the Lewy body variant of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 76:1342–1347PubMedCentralPubMed

168.

Olofsson JK, Nordin S, Wiens S, Hedner M, Nilsson LG, Larsson M (2010) Odor identification impairment in carriers of ApoE-varepsilon4 is independent of clinical dementia. Neurobiol Aging 31:567–577PubMed

169.

Ozdener MH, Rawson NE (2004) Olfactory dysfunction in neurodegenerative diseases. Eur J General Med 1:1–11

170.

Pardini M, Huey ED, Cavanagh AL, Grafman J (2009) Olfactory function in corticobasal syndrome and frontotemporal dementia. Arch Neurol 66:92–96PubMedCentralPubMed

171.

Parrao T, Chana P, Venegas P, Behrens MI, Aylwin ML (2012) Olfactory deficits and cognitive dysfunction in Parkinson’s disease. Neurodegener Dis 10:179–182PubMed

172.

Patel RM, Pinto JM (2014) Olfaction: anatomy, physiology, and disease. Clin Anat 27:54–60PubMed

173.

Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M (2008) Detection of Huntington’s disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 79:874–880PubMedCentralPubMed

174.

Pearce RK, Hawkes CH, Daniel SE (1995) The anterior olfactory nucleus in Parkinson’s disease. Mov Disord 10:283–287PubMed

175.

Perry G, Castellani RJ, Smith MA, Harris PL, Kubat Z, Ghanbari K, Jones PK, Cordone G, Tabaton M, Wolozin B, Ghanbari H (2003) Oxidative damage in the olfactory system in Alzheimer’s disease. Acta Neuropathol 106:552–556PubMed

176.

Petit GH, Berkovich E, Hickery M, Kallunki P, Fog K, Fitzer-Attas C, Brundin P (2013) Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson’s disease. PLoS ONE 8:e60691PubMedCentralPubMed

177.

Petrovitch H, Duda JE, Abbott RD, Nelson J, Noorigian JV, Tanner CM, Masaki K, White LR, Uyehara-Lock J, Ross W (2008) Lewy pathology in the olfactory bulb is associated with decreased neuron density in the substantia nigra (abstr.). Mov Disord 23(suppl 1):S29

178.

Poddighe S, Bhat KM, Setzu MD, Solla P, Angioy AM, Marotta R, Ruffilli R, Marrosu F, Liscia A (2013) Impaired sense of smell in a Drosophila Parkinson’s model. PLoS ONE 8:e73156PubMedCentralPubMed

179.

Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters E, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. Ann Neurol 56:173–181PubMed

180.

Ponsen MM, Stoffers D, Wolters E, Booij J, Berendse HW (2010) Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson’s disease. J Neurol Neurosurg Psychiatry 81:396–399PubMed

181.

Postuma RB, Gagnon JF, Vendette M, Desjardins C, Montplaisir JY (2011) Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 69:811–818PubMed

182.

Prediger RD, Batista LC, Medeiros R, Pandolfo P, Florio JC, Takahashi RN (2006) The risk is in the air: intranasal administration of MPTP to rats reproducing clinical features of Parkinson’s disease. Exp Neurol 202:391–403PubMed

183.

Rahayel S, Frasnelli J, Joubert S (2012) The effect of Alzheimer’s disease and Parkinson’s disease on olfaction: a meta-analysis. Behav Brain Res 231:60–74PubMed

184.

Rajapaksha TW, Eimer WA, Bozza TC, Vassar R (2011) The Alzheimer’s beta-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb. Mol Neurodegener 6:88PubMedCentralPubMed

185.

Rawson NE, Gomez G, Cowart B, Restrepo D (1998) The use of olfactory receptor neurons (ORNs) from biopsies to study changes in aging and neurodegenerative diseases. Ann NY Acad Sci 855:701–707PubMed

186.

Rey NL, Jardanhazi-Kurutz D, Terwel D, Kummer MP, Jourdan F, Didier A, Heneka MT (2012) Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice. Neurobiol Aging 33:426e1–426e11

187.

Rey NL, Petit GH, Bousset L, Melki R, Brundin P (2013) Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol 126:555–573PubMedCentralPubMed

188.

Rolheiser TM, Fulton HG, Good KP, Fisk JD, McKelvey JR, Scherfler C, Khan NM, Leslie RA, Robertson HA (2011) Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson’s disease. J Neurol 258:1254–1260PubMed

189.

Ronnett GV, Leopold D, Cai X, Hoffbuhr KC, Moses L, Hoffman EP, Naidu S (2003) Olfactory biopsies demonstrate a defect in neuronal development in Rett’s syndrome. Ann Neurol 54:206–218PubMed

190.

Ross GW, Abbott RD, Petrovitch H, Tanner CM, Davis DG, Nelson J, Markesbery WR, Hardman J, Masaki K, Launer L, White LR (2006) Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord 21:2062–2067PubMed

191.

Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, Launer L, White LR (2008) Association of olfactory dysfunction with risk for future Parkinson’s disease. Ann Neurol 63:167–173PubMed

192.

Ruan Y, Zheng XY, Zhang HL, Zhu W, Zhu J (2012) Olfactory dysfunctions in neurodegenerative disorders. J Neurosci Res 90:1693–1700PubMed

193.

Ruiz-Martinez J, Gorostidi A, Goyenechea E, Alzualde A, Poza JJ, Rodriguez F, Bergareche A, Moreno F, Lopez de Munain A, Marti Masso JF (2011) Olfactory deficits and cardiac 123I-MIBG in Parkinson’s disease related to the LRRK2 R1441G and G2019S mutations. Mov Disord 26:2026–2031PubMed

194.

Sajjadian A, Doty RL, Gutnick DN, Chirurgi RJ, Sivak M, Perl D (1994) Olfactory dysfunction in amytrophic lateral sclerosis. Neurodegeneration 3:153–157

195.

Sattler R, Ayukawa Y, Coddington L, Sawa A, Block D, Chipkin R, Rothstein JD (2011) Human nasal olfactory epithelium as a dynamic marker for CNS therapy development. Exp Neurol 232:203–211PubMedCentralPubMed

196.

Saunders-Pullman R, Stanley K, Wang C, San Luciano M, Shanker V, Hunt A, Severt L, Raymond D, Ozelius LJ, Lipton RB, Bressman SB (2011) Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology 77:319–324PubMedCentralPubMed

197.

Scherfler C, Schocke MF, Seppi K, Esterhammer R, Brenneis C, Jaschke W, Wenning GK, Poewe W (2006) Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson’s disease. Brain 129:538–542PubMed

198.

Scherfler C, Esterhammer R, Nocker M, Mahlknecht P, Stockner H, Warwitz B, Spielberger S, Pinter B, Donnemiller E, Decristoforo C, Virgolini I, Schocke M, Poewe W, Seppi K (2013) Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson’s disease. Brain 136:3028–3037PubMed

199.

Schneider F, Habel U, Reske M, Toni I, Falkai P, Shah NJ (2007) Neural substrates of olfactory processing in schizophrenia patients and their healthy relatives. Psychiatry Res 155:103–112PubMed

200.

Schofield PW, Ebrahimi H, Jones AL, Bateman GA, Murray SR (2012) An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease. BMC Neurol 12:24PubMedCentralPubMed

201.

Sengoku R, Saito Y, Ikemura M, Hatsuta H, Sakiyama Y, Kanemaru K, Arai T, Sawabe M, Tanaka N, Mochizuki H, Inoue K, Murayama S (2008) Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb. J Neuropathol Exp Neurol 67:1072–1083PubMed

202.

Serby M, Larson P, Kalkstein D (1991) The nature and course of olfactory deficits in Alzheimer’s disease. Am J Psychiatry 148:357–360PubMed

203.

Shah M, Muhammed N, Findley LJ, Hawkes CH (2008) Olfactory tests in the diagnosis of essential tremor. Parkinsonism Relat Disord 14:563–568PubMed

204.

Siderowf A, Jennings D, Connolly J, Doty RL, Marek K, Stern MB (2007) Risk factors for Parkinson’s disease and impaired olfaction in relatives of patients with Parkinson’s disease. Mov Disord 22:2249–2255PubMed

205.

Siderowf A, Jennings D, Eberly S, Oakes D, Hawkins KA, Ascherio A, Stern MB, Marek K (2012) Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Mov Disord 27:406–412PubMed

206.

Sierra M, Sanchez-Juan P, Martinez-Rodriguez MI, Gonzalez-Aramburu I, Garcia-Gorostiaga I, Quirce MR, Palacio E, Carril JM, Berciano J, Combarros O, Infante J (2013) Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease. Neurology 80:621–626PubMed

207.

Silveira-Moriyama L, Guedes LC, Kingsbury A, Ayling H, Shaw K, Barbosa ER, Bonifati V, Quinn NP, Abou-Sleiman P, Wood NW, Petrie A, Sampaio C, Ferreira JJ, Holton J, Revesz T, Lees AJ (2008) Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology 71:1021–1026PubMed

208.

Silveira-Moriyama L, Holton JL, Kingsbury A, Ayling H, Petrie A, Sterlacci W, Poewe W, Maier H, Lees AJ, Revesz T (2009) Regional differences in the severity of Lewy body pathology across the olfactory cortex. Neurosci Lett 453:77–80PubMed

209.

Silveira-Moriyama L, Mathias C, Mason L, Best C, Quinn NP, Lees AJ (2009) Hyposmia in pure autonomic failure. Neurology 72:1677–1681PubMed

210.

Silveira-Moriyama L, Schwingenschuh P, O’Donnell A, Schneider SA, Mir P, Carrillo F, Terranova C, Petrie A, Grosset DG, Quinn NP, Bhatia KP, Lees AJ (2009) Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs). J Neurol Neurosurg Psychiatry 80:744–748PubMed

211.

Silveira-Moriyama L, Munhoz RP, de Carvalho M, Raskin S, Rogaeva E, de Aguiar CAP, Bressan RA, Felicio AC, Barsottini OG, Andrade LA, Chien HF, Bonifati V, Barbosa ER, Teive HA, Lees AJ (2010) Olfactory heterogeneity in LRRK2 related Parkinsonism. Mov Disord 25:2879–2883

212.

Sliger M, Lander T, Murphy C (2004) Effects of the ApoE epsilon4 allele on olfactory function in Down syndrome. J Alzheimers Dis 6:397–402 (discussion 443–399)PubMed

213.

Stephenson R, Houghton D, Sundarararjan S, Doty RL, Stern M, Xie SX, Siderowf A (2010) Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson’s disease. Mov Disord 25:2099–2104PubMedCentralPubMed

214.

Stiasny-Kolster K, Doerr Y, Moller JC, Hoffken H, Behr TM, Oertel WH, Mayer G (2005) Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128:126–137PubMed

215.

Struble RG, Clark HB (1992) Olfactory bulb lesions in Alzheimer’s disease. Neurobiol Aging 13:469–473PubMed

216.

Sun GH, Raji CA, Maceachern MP, Burke JF (2012) Olfactory identification testing as a predictor of the development of Alzheimer’s dementia: a systematic review. Laryngoscope 122:1455–1462PubMed

217.

Tabaton M, Monaco S, Cordone MP, Colucci M, Giaccone G, Tagliavini F, Zanusso G (2004) Prion deposition in olfactory biopsy of sporadic Creutzfeldt-Jakob disease. Ann Neurol 55:294–296PubMed

218.

Takeda A (2013) Severe olfactory dysfunction is a predictor of dementia with Parkinson’s disease. Rinsho Shinkeigaku 53:91–97PubMed

219.

Takeda T, Uchihara T, Kawamura S, Ohashi T (2014) Olfactory dysfunction related to TDP-43 pathology in amyotrophic lateral sclerosis. Clin Neuropathol 33:65–67PubMed

220.

Talamo BR, Rudel R, Kosik KS, Lee VM, Neff S, Adelman L, Kauer JS (1989) Pathological changes in olfactory neurons in patients with Alzheimer’s disease. Nature 337:736–739PubMed

221.

Talamo BR, Feng WH, Perez-Cruet M, Adelman L, Kosik K, Lee MY, Cork LC, Kauer JS (1991) Pathologic changes in olfactory neurons in Alzheimer’s disease. Ann NY Acad Sci 640:1–7PubMed

222.

ter Laak HJ, Renkawek K, van Workum FP (1994) The olfactory bulb in Alzheimer disease: a morphologic study of neuron loss, tangles, and senile plaques in relation to olfaction. Alzheimer Dis Assoc Disord 8:38–48PubMed

223.

Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800PubMed

224.

Thomann PA, Dos Santos V, Seidl U, Toro P, Essig M, Schroder J (2009) MRI-derived atrophy of the olfactory bulb and tract in mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis 17:213–221PubMed

225.

Thompson MD, Knee K, Golden CJ (1998) Olfaction in persons with Alzheimer’s disease. Neuropsychol Rev 8:11–23PubMed

226.

Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC, Wolters EC (2001) Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis. Mov Disord 16:41–46PubMed

227.

Tofaris GK, Garcia Reitbock P, Humby T, Lambourne SL, O’Connell M, Ghetti B, Gossage H, Emson PC, Wilkinson LS, Goedert M, Spillantini MG (2006) Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1–120): implications for Lewy body disorders. J Neurosci 26:3942–3950PubMed

228.

Trojanowski JQ, Newman PD, Hill WD, Lee VM (1991) Human olfactory epithelium in normal aging, Alzheimer’s disease, and other neurodegenerative disorders. J Comp Neurol 310:365–376PubMed

229.

Tsuboi Y, Wszolek ZK, Graff-Radford NR, Cookson N, Dickson DW (2003) Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. Neuropathol Appl Neurobiol 29:503–510PubMed

230.

Turetsky BI, Hahn CG, Borgmann-Winter K, Moberg PJ (2009) Scents and nonsense: olfactory dysfunction in schizophrenia. Schizophr Bull 35:1117–1131PubMedCentralPubMed

231.

Ubeda-Banon I, Saiz-Sanchez D, de la Rosa-Prieto C, Argandona-Palacios L, Garcia-Munozguren S, Martinez-Marcos A (2010) alpha-Synucleinopathy in the human olfactory system in Parkinson’s disease: involvement of calcium-binding protein- and substance P-positive cells. Acta Neuropathol 119:723–735PubMed

232.

Ubeda-Banon I, Saiz-Sanchez D, de la Rosa-Prieto C, Mohedano-Moriano A, Fradejas N, Calvo S, Argandona-Palacios L, Garcia-Munozguren S, Martinez-Marcos A (2010) Staging of alpha-synuclein in the olfactory bulb in a model of Parkinson’s disease: cell types involved. Mov Disord 25:1701–1707PubMed

233.

Ubeda-Banon I, Saiz-Sanchez D, de la Rosa-Prieto C, Martinez-Marcos A (2012) alpha-Synuclein in the olfactory system of a mouse model of Parkinson’s disease: correlation with olfactory projections. Brain Struct Funct 217:447–458PubMed

234.

Ubeda-Banon I, Saiz-Sanchez D, de la Rosa-Prieto C, Martinez-Marcos A (2013) alpha-Synuclein in the olfactory system in Parkinson’s disease: role of neural connections on spreading pathology. Brain Struct Funct in print. doi:10.1007/s00429-00013-00651-00422

235.

Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685–697PubMed

236.

van de Berg W, Zweekhorst S, Voorn P, Groenewegen H, Hoogland P, Rozemuller AM (2007) Pattern of a-synuclein and phosphorylated tau pathology in the olfactory bulb, brainstem and limbic regions in aged individuals (abstr.). Parkinsonism Relat Disord 13:S122

237.

Velazquez-Perez L, Fernandez-Ruiz J, Diaz R, Gonzalez RP, Ochoa NC, Cruz GS, Mederos LE, Gongora EM, Hudson R, Drucker-Colin R (2006) Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases. J Neurol 253:1165–1169PubMed

238.

Verbaan D, Boesveldt S, van Rooden SM, Visser M, Marinus J, Macedo MG, Fang Y, Heutink P, Berendse HW, van Hilten JJ (2008) Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics? Neurology 71:1877–1882PubMed

239.

Wang J, Eslinger PJ, Doty RL, Zimmerman EK, Grunfeld R, Sun X, Meadowcroft MD, Connor JR, Price JL, Smith MB, Yang QX (2010) Olfactory deficit detected by fMRI in early Alzheimer’s disease. Brain Res 1357:184–194PubMedCentralPubMed

240.

Wang J, You H, Liu JF, Ni DF, Zhang ZX, Guan J (2011) Association of olfactory bulb volume and olfactory sulcus depth with olfactory function in patients with Parkinson disease. AJNR Am J Neuroradiol 32:677–681PubMed

241.

Wattendorf E, Welge-Lussen A, Fiedler K, Bilecen D, Wolfensberger M, Fuhr P, Hummel T, Westermann B (2009) Olfactory impairment predicts brain atrophy in Parkinson’s disease. J Neurosci 29:15410–15413PubMed

242.

Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N (1995) Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 91:247–250PubMed

243.

Wesson DW, Levy E, Nixon RA, Wilson DA (2010) Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer’s disease mouse model. J Neurosci 30:505–514PubMedCentralPubMed

244.

Westermann B, Wattendorf E, Schwerdtfeger U, Husner A, Fuhr P, Gratzl O, Hummel T, Bilecen D, Welge-Lussen A (2008) Functional imaging of the cerebral olfactory system in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 79:19–24PubMed

245.

Williams SS, Williams J, Combrinck M, Christie S, Smith AD, McShane R (2009) Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease. J Neurol Neurosurg Psychiatry 80:667–670PubMed

246.

Wilson RS, Arnold SE, Schneider JA, Boyle PA, Buchman AS, Bennett SA (2009) Olfactory impairment in presymptomatic Alzheimer’s disease. In: Finger TE (ed) International Symposium on Olfaction and Taste. New York Academy of Sciences New York, pp 730–735

247.

Wilson RS, Yu L, Schneider JA, Arnold SE, Buchman AS, Bennett DA (2011) Lewy bodies and olfactory dysfunction in old age. Chem Senses 36:367–373PubMedCentralPubMed

248.

Winner B, Geyer M, Couillard-Despres S, Aigner R, Bogdahn U, Aigner L, Kuhn G, Winkler J (2006) Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol 197:113–121PubMed

249.

Winner B, Rockenstein E, Lie DC, Aigner R, Mante M, Bogdahn U, Couillard-Despres S, Masliah E, Winkler J (2008) Mutant alpha-synuclein exacerbates age-related decrease of neurogenesis. Neurobiol Aging 29:913–925PubMedCentralPubMed

250.

Witoonpanich P, Cash DM, Shakespeare TJ, Yong KX, Nicholas JM, Omar R, Crutch SJ, Rossor MN, Warren JD (2013) Olfactory impairment in posterior cortical atrophy. J Neurol Neurosurg Psychiatry 84:588–590PubMedCentralPubMed

251.

Witt M, Bormann K, Reichmann H, Gudziol V, Hähner A, Barth K, Hummel T (2008) Olfactory epithelium in patients with Parkinson’s disease (Abstr.). 6th Int Congr Mental Dysfunctions & Other Non-Motor Features in Parkinson’s Disease and Related Disorders, Dresden, Oct 16-19, 2008 Abstracts on CD-ROM, Kenes International, Geneva:Abstr.# 117

252.

Witt M, Bormann K, Gudziol V, Pehlke K, Barth K, Minovi A, Hahner A, Reichmann H, Hummel T (2009) Biopsies of olfactory epithelium in patients with Parkinson’s disease. Mov Disord 24:906–914PubMed

253.

Wong KK, Muller ML, Kuwabara H, Studenski SA, Bohnen NI (2010) Olfactory loss and nigrostriatal dopaminergic denervation in the elderly. Neurosci Lett 484:163–167PubMed

254.

Wu X, Yu C, Fan F, Zhang K, Zhu C, Wu T, Li K, Chan P (2011) Correlation between progressive changes in piriform cortex and olfactory performance in early Parkinson’s disease. Eur Neurol 66:98–105PubMed

255.

Yamagishi M, Ishizuka Y (1994) Abnormal tau protein expression in biopsied human olfactory mucosa. Nippon Jibiinkoka Gakkai Kaiho 97:466–472PubMed

256.

Yamagishi M, Ishizuka Y, Seki K (1994) Pathology of olfactory mucosa in patients with Alzheimer’s disease. Ann Otol Rhinol Laryngol 103:421–427PubMed

257.

Yamagishi M, Takami S, Getchell TV (1996) Ontogenetic expression of spot 35 protein (calbindin-D28 k) in human olfactory receptor neurons and its decrease in Alzheimer’s disease patients. Ann Otol Rhinol Laryngol 105:132–139PubMed

258.

Yamagishi M, Getchell ML, Takami S, Getchell TV (1998) Increased density of olfactory receptor neurons immunoreactive for apolipoprotein E in patients with Alzheimer’s disease. Ann Otol Rhinol Laryngol 107:421–426PubMed

259.

Yamamoto T (1991) Involvement of the olfactory system in learning and memory: a close correlation between the olfactory deficit and the course of Alzheimer’s disease? Yakubutsu Seishin Kodo 11:223–235PubMed

260.

Zanusso G, Ferrari S, Cardone F, Zampieri P, Gelati M, Fiorini M, Farinazzo A, Gardiman M, Cavallaro T, Bentivoglio M, Righetti PG, Pocchiari M, Rizzuto N, Monaco S (2003) Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease. N Engl J Med 348:711–719PubMed

Titel: Olfactory bulb involvement in neurodegenerative diseases
verfasst von: Johannes Attems
Lauren Walker
Kurt A. Jellinger
Publikationsdatum: 01.04.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Acta Neuropathologica / Ausgabe 4/2014
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-014-1261-7

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2014

α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth

Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms

Impairment of in vivo calcium signaling in amyloid plaque-associated microglia

Supratentorial ependymomas of childhood carry C11orf95–RELA fusions leading to pathological activation of the NF-κB signaling pathway

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions